Tesnatilimab
- Generic Name
- Tesnatilimab
- Drug Type
- Biotech
- CAS Number
- 2242758-08-1
- Unique Ingredient Identifier
- 2B860WP9F0
- Background
Tesnatilimab is under investigation in clinical trial NCT04655807 (A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath